Handling Medium for ICSI With Ionomycin and Latrunculin A
Not Applicable
Completed
- Conditions
- Infertility
- Registration Number
- NCT03678610
- Lead Sponsor
- Ibn Sina Hospital
- Brief Summary
Using Latrunculin A and Ionomycin would improve the outcome of ICSI if the handling medium during the ICSI procedure has them.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 700
Inclusion Criteria
- indication for ICSI
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Fertilization rate 6 days of culture
- Secondary Outcome Measures
Name Time Method clinical pregnancy rate three months Rates of Blastocyst formation and quality 6 days of culture Number of formed blastocysts and blastocysts with good-quality per fertilized oocytes
embryo utilization rate 6 days of culture ongoing pregnancy rate 12 weeks
Trial Locations
- Locations (3)
Banon Assiut
🇪🇬Assiut, Egypt
Qena Fertility Center
🇪🇬Qena, Egypt
IbnSina IVF Center
🇪🇬Sohag, Egypt
Banon Assiut🇪🇬Assiut, Egypt